Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Sep 11, 2020
In the span of a decade, the Acromegaly pipeline therapies, including IONIS-GHR-LRx (Ionis Pharmaceuticals), ATL1103 (Antisense Therapeutics), CAM2029 (Camurus), Veldoreotide (Strongbridge Biopharma), CRN00808 (Crinetics Pharmaceuticals), and Lanreotide PRF (Ipsen) are set to launch. What happens when the grow...
Read More...
Feb 08, 2019
https://www.slideshare.net/DelveInsight/acromegaly-and-gigantism-therapeutics-2?qid=ed224bb4-073c-4c5a-acdc-a02b6bad09d7&v=&b=&from_search=6 Acromegaly :-The excessive Growth Hormone comes from benign tumors on the pituitary. It is rare but serious hormonal disorder.
Read More...
Apr 10, 2017
Gigantism is excessive production of Growth Hormone (GH) in children which is extremely rare and leads to exaggerated bone growth and an abnormal increase in height. It results from high linear growth due to excessive action of insulin-like growth factor I (IGF-I) while the epiphyseal growth plates are open during c...
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper